scienceliberal
The Many Faces of EGFR: How Ligands Shape Its Dance
Sunday, December 29, 2024
Think about it like this: EGFR is like a manager in a busy office. How it behaves depends on who it's working with. Some partners make it act in a certain way, while others change its behavior completely. This discovery could lead to new medicines that target EGFR or its partners better. It's like having a magic wand that can change how the manager works.
Actions
flag content